109
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Efficacy and Safety of Nemonoxacin in Outpatients with Community-Acquired Pneumonia

, ORCID Icon, &
Pages 2099-2104 | Published online: 02 Jul 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Antonio Vena, Nadia Castaldo, Laura Magnasco, Martina Bavastro, Alessandro Limongelli, Daniele Roberto Giacobbe & Matteo Bassetti. (2023) Current and emerging drug treatment strategies to tackle invasive community-associated methicillin-resistant Staphylococcus aureus (MRSA) infection: what are the challenges?. Expert Opinion on Pharmacotherapy 24:3, pages 331-346.
Read now
Susanna Esposito, Alberto Argentiero, Francesca Rebecchi, Valentina Fainardi, Giovanna Pisi & Nicola Principi. (2022) The remaining unsolved problems for rational antibiotic therapy use in pediatric community-acquired pneumonia. Expert Opinion on Pharmacotherapy 23:4, pages 497-505.
Read now

Articles from other publishers (3)

Jinyi Yuan, Xiaoping Zhang, Jing Chen, Yueyuan Zhang, Fengjia Zhu & Haihui Huang. (2022) Safety of oral nemonoxacin: A systematic review of clinical trials and postmarketing surveillance. Frontiers in Pharmacology 13.
Crossref
Junchen Huang, Siwei Guo, Xin Li, Fang Yuan, You Li, Bing Xu, Junyuan Gu & Yong Qiao. (2022) Nemonoxacin Enhances Antibacterial Activity and Anti-Resistance Mutation Ability of Vancomycin against Methicillin-Resistant Staphylococcus aureus in an In Vitro Dynamic Pharmacokinetic/Pharmacodynamic Model . Antimicrobial Agents and Chemotherapy 66:2.
Crossref
. (2020) Nemonoxacin. Reactions Weekly 1819:1, pages 211-211.
Crossref